Last reviewed · How we verify
Ascorbate-Meglumine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Ascorbate-Meglumine (Ascorbate-Meglumine) — LadeRx LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ascorbate-Meglumine TARGET | Ascorbate-Meglumine | LadeRx LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ascorbate-Meglumine CI watch — RSS
- Ascorbate-Meglumine CI watch — Atom
- Ascorbate-Meglumine CI watch — JSON
- Ascorbate-Meglumine alone — RSS
Cite this brief
Drug Landscape (2026). Ascorbate-Meglumine — Competitive Intelligence Brief. https://druglandscape.com/ci/ascorbate-meglumine. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab